News
With an estimated 1.5 million new cases and 397,000 deaths worldwide, prostate cancer is the world's second most frequent ...
13h
MedPage Today on MSNFracture Risk Down With Osteoporosis Drug in Metastatic Prostate CancerWith regard to the choice of bone-protecting agent, denosumab (Xgeva) improved bone density and reduced fracture risk in a placebo-controlled trial involving men with non-metastatic HSPC. Denosumab ...
Pharmaceutical scientists, clinicians, nurses and pharmacists from the National University of Singapore (NUS) and National University Hospital (NUH) have shown that a reduced dose of abiraterone ...
Results of a study led by VHIO’s Prostate Cancer Group suggest that treatment with CDK4/6 inhibitors followed by senloytic ...
Research confirms that many men with nonmetastatic prostate cancer will not die of their disease once they received recommended treatment.
Now that the former president has been diagnosed, he faces a long road of treatment. The bones, where Biden’s cancer has already metastasized, are among the most common sites for prostate cancer ...
In tandem with CURE’s Educated Patient Prostate Cancer Summit, Dr. Kelly Stratton answered common queries related to these treatment options for localized prostate cancer. Stratton, who served as the ...
9d
News Medical on MSNGuideline-based prostate cancer treatment helps most men outlive the diseaseMost men who are treated for prostate cancer according to modern guidelines have good survival rates and the majority of ...
Prostate cancer: screening and treatment options. Mayo Clinic News Network; May 23, 2025 May 23, 2025 Updated May 23, 2025; Facebook; Twitter; ... If prostate cancer is found, ...
About 1 in 8 American men will get a prostate cancer diagnosis, ... The former Democratic president and two-term vice president is reviewing his treatment options with family and physicians, ...
What to know about prostate cancer: symptoms, treatment and when to get screened Former President Joe Biden, 82, has been diagnosed with an aggressive form of prostate cancer that has spread to ...
Pharmaceutical scientists, clinicians, nurses and pharmacists from the National University of Singapore (NUS) and National University Hospital (NUH) have shown that a reduced dose of abiraterone ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results